Welcome to Drug and Alcohol Treatment
| ||
Alcohol Treatment Efficacy Article
![]()
This is a selection made from among articles on Alcohol Treatment Efficacy. For a permanent link to this article, or to bookmark it for future reading, click here.
Drug addiction
from: When looking at drug use, drug abuse, drug dependency and drug addiction, one finds that there are many divergent opinions about these terms and how they identify the drug-using behaviors of the public. Dr. Alan Leshner, the Director of the National Institute of Drug Abuse for the U.S. Government, states: "There is a unique disconnect between scientific facts and the public's perception of drug addiction,"From a lecture in March, 1998 at the National Institutes of Health, Dr. Leshner explained how brain function is modified by drug use and how that change persists after an individual stops taking drugs. Addiction also has to be recognized as a result of many bio-behavioral factors.
Dr. Leshner said a user does not have control over the change when voluntary drug use becomes a compulsive addiction. He likens the change to a flip of a switch, although the change may be a result of opponent processes where changes have accumulated over time. Regardless, Dr. Leshner believes it is important that people understand that once addicted, a person is literally in a different brain state.
Anyone that has known and witnessed the changes in behavior and ethics in a person caught in the thralls of addiction can see the declining spiral of personal care and ethics, work ethics, emotional stability and generally, a feeling that one hardly recognizes the addicted person as being the same individual as they were before the drug use.
One very important point to know is that any drug use may set off these destructive behaviors in an individual and that using drugs “recreationally” is playing Russian Roulette with one’s life. The effects of these “poisons” on the brain and nervous system are always destructive, but the timeline of when the effects will be obvious varies from immediately to, sometimes, after years of “casual” use.
The scientist’s say that one of the tasks of treatment is to revert the brain to its original state or repairing the damage that these poisons can do. Some scientist believe that this can be done by introducing other drugs, then called medicines, into the delicate brain chemistry of someone suffering from drug addiction. That is what National Institute of Drug Abuse (NIDA) is doing now as it begins to design new medications. "We have molecular targets," Dr. Leshner said.” We don't need serendipity." Serendipity is defined as “a natural gift for making useful discoveries by accident.”
However, don’t be fooled by the scientist since they have yet to discover any medications that restore a person to full and, more importantly, enthusiastic living. These “medicines” are always a tradeoff in giving up some of the beauties of life to keep the addict from using a more destructive drug. For a total cure, one should pursue getting the original poisons out of the body and letting the body’s natural repair mechanism restore the person to his original, functional and loving self.
>Drug rehab centers services
About Author
William Kent McGregor, M.S.W., A.C.S.W.
Mr. McGregor received his B.S. degree in psychotropic pharmacology and drug interactions and his Masters of Social Work from the University of Houston. He has served for the State of New Mexico as Director for Drug Treatment and Prevention. He is currently a surveyor for the national Commission on Accreditation of Rehabilitation Facilities.
>Drug rehab centers services
Source: ArticleTrader.com
Alcohol Treatment Efficacy Specific links
Alcohol Treatment Efficacy News
A hope for release from demon alcohol - Sarasota Herald-Tribune
![]() Sarasota Herald-Tribune | A hope for release from demon alcohol Sarasota Herald-Tribune But the significance of these drugs far exceeds their efficacy, addiction experts say. “When I went to medical school, if you suggested targeting alcoholism with a drug, people would say to you, 'Young man, how could you ever hope to treat a chemical ... |
Omron Launches Sleep Monitor With ResMed Technology - MarketWatch (press release)
Omron Launches Sleep Monitor With ResMed Technology MarketWatch (press release) ResMed is a leading developer, manufacturer and distributor of systems to diagnose, treat and manage sleep-disordered breathing, a serious health condition in which people experience breathing issues during sleep ranging from simple snoring to periods ... |
Kudzu root components may treat alcoholism and curb binge drinking - News-Medical.net
![]() RedOrbit | Kudzu root components may treat alcoholism and curb binge drinking News-Medical.net An extract of the Chinese herb kudzu dramatically reduces drinking and may be useful in the treatment of alcoholism and curbing binge drinking, according to a new study by McLean Hospital and Harvard Medical School researchers. Chinese Herb Kudzu Reduces Consumption Of Alcohol Chinese Herb Kudzu Reduces Alcohol Consumption |
Phase 3 Data Show NUCYNTA® ER (tapentadol) Extended-Release Tablets Provide ... - MarketWatch (press release)
Phase 3 Data Show NUCYNTA® ER (tapentadol) Extended-Release Tablets Provide ... MarketWatch (press release) Following randomization, during the double-blind treatment phase to week 12, pain increased in the placebo group (as demonstrated by the mean change in pain intensity of 1.3), while in the tapentadol ER group, efficacy was maintained, as indicated by ... |
Lightlake Therapeutics Inc. Announces Positive Preliminary Phase II Clinical ... - MarketWatch (press release)
Lightlake Therapeutics Inc. Announces Positive Preliminary Phase II Clinical ... MarketWatch (press release) The reduction in bingeing showed the same pattern across time (called an "extinction curve") as has been previously reported for the treatment of alcohol dependence with similar opioid antagonists. The behavior shows little change during the first few ... |
Vivus Announces FDA Approval Of STENDRA(TM) (avanafil) Tablets For The ... - MarketWatch (press release)
Vivus Announces FDA Approval Of STENDRA(TM) (avanafil) Tablets For The ... MarketWatch (press release) "We believe that the PDE5 selectivity and absorption profile of STENDRA make it an important new treatment option for many men with erectile dysfunction." More than 1200 men with ED participated in clinical studies evaluating the efficacy and safety of ... |
Pfizer Announces New Long-Term Relapse Prevention Data For PRISTIQ(R ... - MarketWatch (press release)
Pfizer Announces New Long-Term Relapse Prevention Data For PRISTIQ(R ... MarketWatch (press release) These new data, and data from a study in peri- and post-menopausal women with MDD, add to the existing efficacy and safety profile of PRISTIQ for the treatment of MDD. Lastly, new data also provide information regarding the discontinuation of PRISTIQ ... |
Saint Jude Retreats Raises Awareness About "Addiction" - DigitalJournal.com (press release)
Saint Jude Retreats Raises Awareness About "Addiction" DigitalJournal.com (press release) Saint Jude Retreats, today's leading alternative program to drug and alcohol rehab announces tips the public should know about addiction. Realizing The Choice: First off, Saint Jude's educates guests that addiction means nothing other than a devotion. |
Alcoholic help group funds run dry - The Age
Alcoholic help group funds run dry The Age ''For some people, residential rehab might be really important, but for others, this program works really well because some people can't take three to six months out of their life to recover from an addiction,'' he said. An external evaluation found 63 ... |
Advaxis Announces Cancer Research UK Initiates Phase 1/2 Clinical Trial of ... - MarketWatch (press release)
Advaxis Announces Cancer Research UK Initiates Phase 1/2 Clinical Trial of ... MarketWatch (press release) The study will investigate the safety and efficacy of this novel immunotherapeutic agent in preventing recurrence of head and neck cancer among patients who have been treated with surgery, radiotherapy, and/or chemotherapy; alone or in combination. |



